Boston, MA–(ENEWSPF)–October 21, 2016. Cannabidiol (CBD) administration is associated with the mitigation of treatment-resistant seizures, according to the findings of several recent clinical trials.
In one trial, investigators at Massachusetts General Hospital assessed CBD treatment over a 12-month period in 18 patients with refractory epileptic seizures due to Tuberous sclerosis complex (TSC). Researchers reported that CBD treatment reduced subjects’ median weekly seizure frequency by half. Authors concluded, “[T]hese findings suggest that cannabidiol may be…
